Summary
Updated Aug 31, 2026
Vincent Levien is Director of Celularity Inc (CELU). 4 SEC Form 4 filings on record going back to 2025, most recently on 15 January 2026.
Recent Transactions
3Every recent SEC Form 4 transaction Vincent Levien has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Vincent Levien's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Helen Torley - $37.86M of HALO open-market activity in the last 12 months
- Kevin Charles Gorman - $37.82M of NBIX open-market activity in the last 12 months
- Emily M. Leproust - $35.18M of TWST open-market activity in the last 12 months
- Tactic Pharma LLC - $35.00M of MNPR open-market activity in the last 12 months
- Roelof Botha - $34.89M of NTRA open-market activity in the last 12 months
- Nello Mainolfi - $34.88M of KYMR open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Vincent Levien?
Vincent Levien is a corporate insider, tracked as Director of Celularity Inc (CELU). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Vincent Levien last file a Form 4?
The most recent primary Form 4 on record is dated 15 January 2026, one of 4 filings going back to 2025.
Where can I see all of Vincent Levien's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Vincent Levien and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
